VivoSim Labs, Inc. (VIVS)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
0.81 USD
-0.07
(-7.975%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.78 -0.03 (-0.027%) ⇩ (July 13, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:12 a.m. EDT
The immediate outlook is severely bearish as the stock has lost nearly 99.8% of its value over the last nine years, with five consecutive years of negative annual returns ending in a sharp decline. Despite recent headlines about distribution deals and AI capabilities, the financial reality shows a company burning through cash with negative operating margins, negative free cash flow, and a trailing P/E that implies massive losses rather than profitability. The balance sheet is fragile with significant debt relative to equity, and there is no dividend to provide any income cushion. While the recent price action shows some volatility, the fundamental deterioration is so profound that the investment case remains non-existent for both short-term traders and long-term holders. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.024118 |
| AutoARIMA | 0.030844 |
| AutoETS | 0.182003 |
| MSTL | 0.200019 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.91 |
| Ljung-Box p | 0.001 |
| Jarque-Bera p | 0.043 |
| Excess Kurtosis | 1.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 18.284 |
| Revenue per Share | 0.061 |
| Market Cap | 2,341,376 |
| Trailing P/E | 0.46 |
| Beta | 1.40 |
| Previous Name | Organovo Holdings, Inc. |
| Website | https://vivosim.ai |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5463917 |
| Address1 | 11,555 Sorrento Valley Road |
| Address2 | Suite 100 |
| All Time High | 3,276.0 |
| All Time Low | 0.78 |
| Ask | 0.9483 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 258,840 |
| Average Daily Volume3 Month | 89,998 |
| Average Volume | 89,998 |
| Average Volume10Days | 258,840 |
| Beta | 1.4 |
| Bid | 0.688 |
| Bid Size | 1 |
| Book Value | 1.703 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.8089 |
| Current Ratio | 2.441 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.891 |
| Day Low | 0.7816 |
| Debt To Equity | 18.284 |
| Display Name | VivoSim Labs |
| Dividend Date | 1,597,795,200 |
| Earnings Timestamp End | 1,754,683,200 |
| Earnings Timestamp Start | 1,754,337,600 |
| Ebitda | -11,221,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.122 |
| Enterprise To Revenue | -9.623 |
| Enterprise Value | -1,366,419 |
| Eps Trailing Twelve Months | 1.76 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.2106 |
| Fifty Day Average Change | -0.40170002 |
| Fifty Day Average Change Percent | -0.33181894 |
| Fifty Two Week Change Percent | -54.63917 |
| Fifty Two Week High | 5.3 |
| Fifty Two Week High Change | -4.4911003 |
| Fifty Two Week High Change Percent | -0.84737736 |
| Fifty Two Week Low | 0.78 |
| Fifty Two Week Low Change | 0.028900027 |
| Fifty Two Week Low Change Percent | 0.03705132 |
| Fifty Two Week Range | 0.78 - 5.3 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,329,229,800,000 |
| Float Shares | 2,325,676 |
| Free Cashflow | -7,895,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -3,781,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14804 |
| Held Percent Institutions | 0.07693 |
| Implied Shares Outstanding | 2,894,519 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Last Split Date | 1,742,515,200 |
| Last Split Factor | 1:12 |
| Long Business Summary | VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California. |
| Long Name | VivoSim Labs, Inc. |
| Market | us_market |
| Market Cap | 2,341,376 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_106718277 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -1,227,000 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 2,544,282 |
| Open | 0.88 |
| Operating Cashflow | -10,624,000 |
| Operating Margins | -105.769226 |
| Payout Ratio | 0.0 |
| Phone | 858 224 1000 |
| Post Market Change | -0.026899993 |
| Post Market Change Percent | -3.3255029 |
| Post Market Price | 0.782 |
| Post Market Time | 1,783,987,135 |
| Prev Name | Organovo Holdings, Inc. |
| Previous Close | 0.879 |
| Price Hint | 4 |
| Price To Book | 0.47498533 |
| Price To Sales Trailing12 Months | 16.488564 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.746 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0701 |
| Regular Market Change Percent | -7.97497 |
| Regular Market Day High | 0.891 |
| Regular Market Day Low | 0.7816 |
| Regular Market Day Range | 0.7816 - 0.891 |
| Regular Market Open | 0.88 |
| Regular Market Previous Close | 0.879 |
| Regular Market Price | 0.8089 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 121,541 |
| Return On Assets | -1.3252001 |
| Return On Equity | -0.51072 |
| Revenue Growth | 0.083 |
| Revenue Per Share | 0.061 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,894,519 |
| Shares Percent Shares Out | 0.0394 |
| Shares Short | 113,911 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 33,344 |
| Short Name | VivoSim Labs, Inc. |
| Short Percent Of Float | 0.0398 |
| Short Ratio | 1.06 |
| Source Interval | 15 |
| State | CA |
| Symbol | VIVS |
| Total Cash | 4,288,000 |
| Total Cash Per Share | 1.644 |
| Total Debt | 812,000 |
| Total Revenue | 142,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.76 |
| Trailing P E | 0.45960227 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.90635 |
| Two Hundred Day Average Change | -1.09745 |
| Two Hundred Day Average Change Percent | -0.57568127 |
| Type Disp | Equity |
| Volume | 121,541 |
| Website | https://vivosim.ai |
| Zip | 92,121 |